Avantax Advisory Services’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$314K Buy
+2,498
New +$311K ﹤0.01% 1875
2024
Q3
Sell
-1,117
Closed -$259K 2129
2024
Q2
$259K Buy
+1,117
New +$243K ﹤0.01% 1796
2023
Q4
Sell
-833
Closed -$214K 1580
2023
Q3
$214K Sell
833
-13
-2% -$3.48K ﹤0.01% 1391
2023
Q2
$241K Sell
846
-43
-5% -$12.8K ﹤0.01% 1303
2023
Q1
$247K Sell
889
-31
-3% -$8.58K ﹤0.01% 1255
2022
Q4
$255K Buy
920
+19
+2% +$5.37K ﹤0.01% 1189
2022
Q3
$241K Buy
+901
New +$191K ﹤0.01% 1112
2022
Q2
Sell
-1,127
Closed -$236K 1313
2022
Q1
$236K Sell
1,127
-36
-3% -$7.83K ﹤0.01% 1118
2021
Q4
$279K Sell
1,163
-1,012
-47% -$260K ﹤0.01% 1011
2021
Q3
$617K Buy
2,175
+648
+42% +$212K 0.01% 637
2021
Q2
$528K Buy
+1,527
New +$463K 0.01% 693
2020
Q4
Sell
-1,753
Closed -$497K 970
2020
Q3
$497K Buy
+1,753
New +$489K 0.01% 784
2020
Q2
Sell
-830
Closed -$264K 854
2020
Q1
$264K Buy
+830
New +$252K 0.01% 625

Other funds holding BIIB